Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Apr;73(8):972–978. doi: 10.1038/bjc.1996.190

Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.

S R Bramhall 1, G W Stamp 1, J Dunn 1, N R Lemoine 1, J P Neoptolemos 1
PMCID: PMC2075817  PMID: 8611434

Abstract

It is now recognised that epithelial-stromal interactions are important in a wide range of disease processes including neoplasia and inflammation. Metalloproteinases are central to matrix degradation and remodelling, which are key events in tumour invasion and metastasis and may also be involved in tissue changes occurring in chronic inflammation. Immunohistochemistry was performed on sections from 50 patients with pancreatic cancer (n = 27), ampullary cancer (n = 12), low bile duct cancer (n = 3), neuroendocrine tumours (n = 3) and chronic pancreatitis (n = 5), using antibodies raised against collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of metalloproteinase (TIMP1) and developed using the avidin-biotin complex method. Abundance of MMP2, MMP3 and TIMP1 was greater in pancreatic and ampullary cancer than any other pathology and immunoreactivity in the malignant epithelial cells in pancreatic and ampullary cancer was greater than in the stromal tissues (in pancreatic cancer: MMP2 100% vs 37%, MMP3 93% vs 15%, TIMP1 93% vs 4%, P < 0.0001). There were strong correlations between the immunoreactivity of the two antibodies for MMP2 (P < 0.0001), between MMP2 and TIMP1 (P < 0.0001) and between MMP3 and TIMP1 (P < 0.0001). The immunoreactivity for TIMP1 in pancreatic and ampullary cancers with lymph node metastases was significantly less compared with those cases without lymph node metastases (P < 0.02) and there was an association between increased immunoreactivity for MMP2 and the degree of tumour differentiation (P < 0.01). The results implicate MMP2, MMP3 and TIMP1 in the invasive phenotype of pancreatic and ampullary cancer.

Full text

PDF
972

Images in this article

975Figure 1
on p.975
975Figure 2
on p.975
976Figure 3
on p.976
976Figure 4
on p.976
976Figure 5
on p.976
977Figure 6
on p.977

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal C., Hembree J. R., Rorke E. A., Eckert R. L. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res. 1994 Feb 15;54(4):943–949. [PubMed] [Google Scholar]
  2. Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990 Dec 20;348(6303):699–704. doi: 10.1038/348699a0. [DOI] [PubMed] [Google Scholar]
  3. Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun. 1982 Dec 15;109(3):1026–1034. doi: 10.1016/0006-291x(82)92042-3. [DOI] [PubMed] [Google Scholar]
  4. Brown P. D., Levy A. T., Margulies I. M., Liotta L. A., Stetler-Stevenson W. G. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 1990 Oct 1;50(19):6184–6191. [PubMed] [Google Scholar]
  5. Charpin C., Lissitzky J. C., Jacquemier J., Lavaut M. N., Kopp F., Pourreau-Schneider N., Martin P. M., Toga M. Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study. Hum Pathol. 1986 Apr;17(4):355–365. doi: 10.1016/s0046-8177(86)80458-0. [DOI] [PubMed] [Google Scholar]
  6. Chin J. R., Murphy G., Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem. 1985 Oct 5;260(22):12367–12376. [PubMed] [Google Scholar]
  7. De Clerck Y. A., Yean T. D., Ratzkin B. J., Lu H. S., Langley K. E. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem. 1989 Oct 15;264(29):17445–17453. [PubMed] [Google Scholar]
  8. Forster S. J., Talbot I. C., Clayton D. G., Critchley D. R. Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance. Int J Cancer. 1986 Jun 15;37(6):813–817. doi: 10.1002/ijc.2910370603. [DOI] [PubMed] [Google Scholar]
  9. Gray S. T., Yun K., Motoori T., Kuys Y. M. Interstitial collagenase gene expression in colonic neoplasia. Am J Pathol. 1993 Sep;143(3):663–671. [PMC free article] [PubMed] [Google Scholar]
  10. Haddock G., Carter D. C. Aetiology of pancreatic cancer. Br J Surg. 1990 Oct;77(10):1159–1166. doi: 10.1002/bjs.1800771025. [DOI] [PubMed] [Google Scholar]
  11. Hamdy F. C., Fadlon E. J., Cottam D., Lawry J., Thurrell W., Silcocks P. B., Anderson J. B., Williams J. L., Rees R. C. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer. 1994 Jan;69(1):177–182. doi: 10.1038/bjc.1994.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hart I. R., Goode N. T., Wilson R. E. Molecular aspects of the metastatic cascade. Biochim Biophys Acta. 1989 Jul 28;989(1):65–84. doi: 10.1016/0304-419x(89)90035-8. [DOI] [PubMed] [Google Scholar]
  13. Hewitt R. E., Leach I. H., Powe D. G., Clark I. M., Cawston T. E., Turner D. R. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer. 1991 Nov 11;49(5):666–672. doi: 10.1002/ijc.2910490507. [DOI] [PubMed] [Google Scholar]
  14. Ito A., Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys. 1988 Nov 15;267(1):211–216. doi: 10.1016/0003-9861(88)90025-2. [DOI] [PubMed] [Google Scholar]
  15. Khokha R., Waterhouse P., Lala P., Zimmer M., Denhardt D. T., Khokka R. Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm? [corrected]. J Cancer Res Clin Oncol. 1991;117(4):333–338. doi: 10.1007/BF01630716. [DOI] [PubMed] [Google Scholar]
  16. Lee C. S., Montebello J., Georgiou T., Rode J. Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. Int J Exp Pathol. 1994 Apr;75(2):79–83. [PMC free article] [PubMed] [Google Scholar]
  17. Liotta L. A., Stetler-Stevenson W. G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991 Sep 15;51(18 Suppl):5054s–5059s. [PubMed] [Google Scholar]
  18. Liotta L. A., Tryggvason K., Garbisa S., Hart I., Foltz C. M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980 Mar 6;284(5751):67–68. doi: 10.1038/284067a0. [DOI] [PubMed] [Google Scholar]
  19. Matrisian L. M., McDonnell S., Miller D. B., Navre M., Seftor E. A., Hendrix M. J. The role of the matrix metalloproteinase stromelysin in the progression of squamous cell carcinomas. Am J Med Sci. 1991 Sep;302(3):157–162. doi: 10.1097/00000441-199109000-00008. [DOI] [PubMed] [Google Scholar]
  20. Miyazaki K., Hattori Y., Umenishi F., Yasumitsu H., Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res. 1990 Dec 15;50(24):7758–7764. [PubMed] [Google Scholar]
  21. Moll U. M., Lane B., Zucker S., Suzuki K., Nagase H. Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line. Cancer Res. 1990 Nov 1;50(21):6995–7002. [PubMed] [Google Scholar]
  22. Mollenhauer J., Roether I., Kern H. F. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas. 1987;2(1):14–24. doi: 10.1097/00006676-198701000-00003. [DOI] [PubMed] [Google Scholar]
  23. Muller D., Quantin B., Gesnel M. C., Millon-Collard R., Abecassis J., Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J. 1988 Jul 1;253(1):187–192. doi: 10.1042/bj2530187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Murphy G., Cockett M. I., Stephens P. E., Smith B. J., Docherty A. J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J. 1987 Nov 15;248(1):265–268. doi: 10.1042/bj2480265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murphy G., Cockett M. I., Ward R. V., Docherty A. J. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991 Jul 1;277(Pt 1):277–279. doi: 10.1042/bj2770277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nagakawa T., Kayahara M., Ueno K., Ohta T., Konishi I., Ueda N., Miyazaki I. A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer. 1992 Feb 15;69(4):930–935. doi: 10.1002/1097-0142(19920215)69:4<930::aid-cncr2820690416>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  27. Nagakawa T., Konishi I., Higashino Y., Ueno K., Ohta T., Kayahara M., Ueda N., Maeda K., Miyazaki I. The spread and prognosis of carcinoma in the region of the pancreatic head. Jpn J Surg. 1989 Sep;19(5):510–518. doi: 10.1007/BF02471656. [DOI] [PubMed] [Google Scholar]
  28. Naylor M. S., Stamp G. W., Davies B. D., Balkwill F. R. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer. 1994 Jul 1;58(1):50–56. doi: 10.1002/ijc.2910580110. [DOI] [PubMed] [Google Scholar]
  29. Neoptolemos J. P., Talbot I. C., Shaw D. C., Carr-Locke D. L. Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasiveness. Cancer. 1988 Apr 1;61(7):1403–1407. doi: 10.1002/1097-0142(19880401)61:7<1403::aid-cncr2820610721>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  30. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem. 1992 Oct 25;267(30):21712–21719. [PubMed] [Google Scholar]
  31. Okada Y., Tsuchiya H., Shimizu H., Tomita K., Nakanishi I., Sato H., Seiki M., Yamashita K., Hayakawa T. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun. 1990 Sep 14;171(2):610–617. doi: 10.1016/0006-291x(90)91190-4. [DOI] [PubMed] [Google Scholar]
  32. Ostrowski L. E., Finch J., Krieg P., Matrisian L., Patskan G., O'Connell J. F., Phillips J., Slaga T. J., Breathnach R., Bowden G. T. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinog. 1988;1(1):13–19. doi: 10.1002/mc.2940010106. [DOI] [PubMed] [Google Scholar]
  33. Overall C. M., Wrana J. L., Sodek J. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem. 1991 Jul 25;266(21):14064–14071. [PubMed] [Google Scholar]
  34. Ponton A., Coulombe B., Skup D. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res. 1991 Apr 15;51(8):2138–2143. [PubMed] [Google Scholar]
  35. Poulsom R., Hanby A. M., Pignatelli M., Jeffery R. E., Longcroft J. M., Rogers L., Stamp G. W. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol. 1993 May;46(5):429–436. doi: 10.1136/jcp.46.5.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Poulsom R., Pignatelli M., Stetler-Stevenson W. G., Liotta L. A., Wright P. A., Jeffery R. E., Longcroft J. M., Rogers L., Stamp G. W. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol. 1992 Aug;141(2):389–396. [PMC free article] [PubMed] [Google Scholar]
  37. Pyke C., Ralfkiaer E., Huhtala P., Hurskainen T., Danø K., Tryggvason K. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 1992 Mar 1;52(5):1336–1341. [PubMed] [Google Scholar]
  38. Russell R. C. Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol. 1990 Dec;4(4):889–916. doi: 10.1016/0950-3528(90)90025-c. [DOI] [PubMed] [Google Scholar]
  39. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 1994 Jul 7;370(6484):61–65. doi: 10.1038/370061a0. [DOI] [PubMed] [Google Scholar]
  40. Shima I., Sasaguri Y., Kusukawa J., Nakano R., Yamana H., Fujita H., Kakegawa T., Morimatsu M. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer. 1993 Apr;67(4):721–727. doi: 10.1038/bjc.1993.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Stetler-Stevenson W. G., Brown P. D., Onisto M., Levy A. T., Liotta L. A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem. 1990 Aug 15;265(23):13933–13938. [PubMed] [Google Scholar]
  42. Taniguchi S., Iwamura T., Katsuki T. Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines. Clin Exp Metastasis. 1992 Jul;10(4):259–266. doi: 10.1007/BF00133561. [DOI] [PubMed] [Google Scholar]
  43. Unemori E. N., Ferrara N., Bauer E. A., Amento E. P. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992 Dec;153(3):557–562. doi: 10.1002/jcp.1041530317. [DOI] [PubMed] [Google Scholar]
  44. Urbanski S. J., Edwards D. R., Hershfield N., Huchcroft S. A., Shaffer E., Sutherland L., Kossakowska A. E. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol. 1993 Jun;2(2):81–89. [PubMed] [Google Scholar]
  45. Uría J. A., Ferrando A. A., Velasco G., Freije J. M., López-Otín C. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 1994 Apr 15;54(8):2091–2094. [PubMed] [Google Scholar]
  46. Welgus H. G., Jeffrey J. J., Eisen A. Z., Roswit W. T., Stricklin G. P. Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res. 1985 Mar;5(2):167–179. doi: 10.1016/s0174-173x(85)80038-8. [DOI] [PubMed] [Google Scholar]
  47. Welgus H. G., Stricklin G. P. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem. 1983 Oct 25;258(20):12259–12264. [PubMed] [Google Scholar]
  48. Wilhelm S. M., Collier I. E., Marmer B. L., Eisen A. Z., Grant G. A., Goldberg G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989 Oct 15;264(29):17213–17221. [PubMed] [Google Scholar]
  49. Yamaguchi K., Enjoji M. Carcinoma of the pancreas: a clinicopathologic study of 96 cases with immunohistochemical observations. Jpn J Clin Oncol. 1989 Mar;19(1):14–22. [PubMed] [Google Scholar]
  50. Yoshimoto M., Itoh F., Yamamoto H., Hinoda Y., Imai K., Yachi A. Expression of MMP-7(PUMP-1) mRNA in human colorectal cancers. Int J Cancer. 1993 Jun 19;54(4):614–618. doi: 10.1002/ijc.2910540415. [DOI] [PubMed] [Google Scholar]
  51. Zucker S., Moll U. M., Lysik R. M., DiMassimo E. I., Schwedes J. W., Liotta L. A. Extraction of type IV collagenase/gelatinase from plasma membranes of human pancreatic cancer cells. Matrix Suppl. 1992;1:411–411. [PubMed] [Google Scholar]
  52. Zucker S., Moll U. M., Lysik R. M., DiMassimo E. I., Stetler-Stevenson W. G., Liotta L. A., Schwedes J. W. Extraction of type-IV collagenase/gelatinase from plasma membranes of human cancer cells. Int J Cancer. 1990 Jun 15;45(6):1137–1142. doi: 10.1002/ijc.2910450625. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES